New Delhi: Leading industry bodies representing medical technology sector on 20th September came together at MTaI MedTekon 2018 to discuss ways to strengthen healthcare delivery under Ayushman Bharat scheme, a government programme to enable the bottom 40 percent of India’s population access healthcare for free.

Representatives of Medical Technology Association of India (MTaI), Advance Medical Technology Association (AdvaMed), AmCham Medical Devices Committee, Confederation of Indian Industries (CII), Healthcare Federation of India (NATHEALTH) and Federation of Indian Chambers of Commerce and Industries (FICCI), underscoring their solidarity, huddled up with government officials, doctors, investors and patients’ groups to chalk out a roadmap for the industry to contribute effectively to the world’s largest healthcare reform programme.

Starting 25th September 2018, the government plans to provide health insurance to 10 crore families and also strengthen the network of primary health centers in the country. Most secondary and tertiary treatments will be covered under the scheme. As per statistics, health insurance has spread only to 27 percent of the population-the cover being sparse-and more than 80 percent of healthcare expenditure is incurred by individuals from their own pockets.

“We admire the vision of inclusion behind Ayushman Bharat and the programme’s massive scale. It has the ability to stimulate the economy due to its impact on the health of the labor force as well as provide a new ecosystem in healthcare business which can sprout a thousand new ladders of commercial success.” MTaI Chairman Mr. Pavan Choudary said.

For the scheme, the government has recommended maximum allowable costing for 1363 health procedures. Mr. Probir Das, Senior Vice President, Healthcare Federation of India (NATHEALTH), said: “The cost structure still needs work. While for many procedures the cost may be optimum, for several, it may require a re-think. The ideal way to resolve this problem will be to keep the cost of medical devices outside the procedure costs. Also, given the fact that international MedTech companies use their global network to train physicians and develop modern therapies in India, they should be considered as a vital pillar for consultation and programme development”.

Mr Badhri Iyengar, Chairman of FICCI’s Medical Devices & Equipment Committee, said: “Medical devices and diagnostic services are very important in health treatments. By the virtue of this, we feel that the medical technology industry is an important stakeholder for Ayushman Bharat. We are committed to contributing in letter and spirit to the successful implementation of the pathbreaking scheme. Today’s deliberations have been important in paving the way for this”.

Mr Madan Krishnan, Chairman, AdvaMed, said “the next stage of today’s constructive dialogue is industry-government dialogue to enhance impact and success of the programme. MedTech industry can actively partner with the government and providers to transform healthcare in India by structuring effective patient care pathways along with outcome based models.”

Mr Diwaker Rana, Co-Chairman MTaI Medtekon said: “A comprehensive view of the healthcare industry should be taken to make it rewarding for all stakeholders. This will poise it for success.”

“The Ayushman Bharat Scheme will significantly bring down the out of pocket healthcare expenses and have an indirect impact on individual wealth which will lead to economic growth of the nation. The other longer term and most important impact of the scheme will be the data repository through AB-NHPM, it will facilitate research and evidence-based decision making in future.” added Mr Himanshu Baid, Chairman of Medical technology Division, CII.

The summit was inaugurated by Dr Vinod K. Paul, Member, NITI Aayog. In his speech, Dr Paul said “Ayushman Bharat is based on three pillars: Primary Health, Diagnosis and Health Insurance. The scheme at present takes care of lowest two quintiles of our population. It is an integrated healthcare scheme where we have integrated the public and private sectors and given patients the power to decide where they want to access the healthcare services from. To me, it is an anti-poverty measure which prevents people from falling into poverty due to healthcare requirements. I believe if we save a healthy life for a year, we can add 1.5% to the GDP.”

Dr Paul urged the international fraternity to suggest how they can contribute to Ayushman Bharat scheme. “The international fraternity can help us strengthen the scheme going forward. They have a strong R&D, can bring investments for Make in India, set up health and wellness centres through their CSR centers and train healthcare professionals. I would like to ask the fraternity to come up with ideas on how they can contribute to the scheme,” he added.

During the summit, MTaI unveiled a theme paper entitled ‘MedTech – The Keystone for Ayushman Bharat’. The paper presents Ayushman Bharat scheme in summary and points out the concerns of stakeholders which need to be dovetailed to ensure success. The theme paper also brings out the possible solution to these concerns.

“For the success of the Ayushman Bharat programme, it will require the coordinated action of all stakeholders in the complex healthcare industry including health insurers and TPAs, providers, the pharmaceutical industry, the medical device & diagnostic industryAyushman Bharat has the potential to transform the perception of the Indian public towards government healthcare schemes. It will be no small feat to achieve the core objectives that it has set for itself and if the scheme is implemented in a methodical, systematic and well researched manner, the Healthcare landscape shall truly be transformed.” the paper states.

Face to Face

Mentioned Dr Geetha Manjunath, CEO & CTO of Bangalore-based healthtech startup NIRAMAI in an exclusive interaction with BioVoice where she spoke about the artificial intelligence in healthcare and an innovative early breast cancer detection technology developed by her company...….

Subscribe Our Newsletter

Email Address

Chat with BioVoice

Mentioned Dr Debarka Sengupta in an exclusive interaction with the BioVoice, where he explained the idea and importance of FiRE, a novel algorithm that can detect rare cell types at a very fast speed developed by his team at the Indian Institute of Technology-Delhi...……….

The BioVoice is an independent media outlet for coverage of Indian bioscience sector through its 24*7 live web portal, bi-annual digital magazine and soon to be launched app. Founded in 2015, this vibrant news platform connects various dots... Read More